Literature DB >> 27775222

Monitoring macular pigment changes in macular holes using fluorescence lifetime imaging ophthalmoscopy.

Lydia Sauer1, Sven Peters1, Johanna Schmidt1, Dietrich Schweitzer1, Matthias Klemm2, Lisa Ramm3, Regine Augsten1, Martin Hammer1,4.   

Abstract

PURPOSE: To investigate the impact of macular pigment (MP) on fundus autofluorescence (FAF) lifetimes in vivo by characterizing full-thickness idiopathic macular holes (MH) and macular pseudo-holes (MPH).
METHODS: A total of 37 patients with MH and 52 with MPH were included. Using the fluorescence lifetime imaging ophthalmoscope (FLIO), based on a Heidelberg Engineering Spectralis system, a 30° retinal field was investigated. FAF decays were detected in a short (498-560 nm; ch1) and long (560-720 nm; ch2) wavelength channel. τm , the mean fluorescence lifetime, was calculated from a three-exponential approximation of the FAF decays. Macular coherence tomography scans were recorded, and macular pigment's optical density (MPOD) was measured (one-wavelength reflectometry). Two MH subgroups were analysed according to the presence or absence of an operculum above the MH. A total of 17 healthy fellow eyes were included. A longitudinal FAF decay examination was conducted in nine patients, which were followed up after surgery and showed a closed MH.
RESULTS: In MH without opercula, significant τm differences (p < 0.001) were found between the hole area (MHa) and surrounding areas (MHb) (ch1: MHa 238 ± 64 ps, MHb 181 ± 78 ps; ch2: MHa 275 ± 49 ps, MHb 223 ± 48 ps), as well as between MHa and healthy eyes or closed MH. Shorter τm , adjacent to the hole, can be assigned to areas with equivalently higher MPOD. Opercula containing MP also show short τm . In MPH, the intactness of the Hele fibre layer is associated with shortest τm .
CONCLUSIONS: Shortest τm originates from MP-containing retinal layers, especially from the Henle fibre layer. Fluorescence lifetime imaging ophthalmoscope (FLIO) provides information on the MP distribution, the pathogenesis and topology of MH. Macular pigment (MP) fluorescence may provide a biomarker for monitoring pathological changes in retinal diseases.
© 2016 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990FLIOzzm321990; fluorescence lifetime imaging; macular holes; macular pigment

Mesh:

Year:  2016        PMID: 27775222     DOI: 10.1111/aos.13269

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  15 in total

1.  Fundus autofluorescence beyond lipofuscin: lesson learned from ex vivo fluorescence lifetime imaging in porcine eyes.

Authors:  Martin Hammer; Lydia Sauer; Matthias Klemm; Sven Peters; Rowena Schultz; Jens Haueisen
Journal:  Biomed Opt Express       Date:  2018-06-11       Impact factor: 3.732

2.  Simplified approach to least-square fitting of fluorescence lifetime ophthalmoscopy (FLIO) data by fixating lifetimes.

Authors:  Rowena Schultz; Franziska Schuster; Thomas Lehmann; Johanna Schmidt; Regine Augsten; Martin Hammer
Journal:  Biomed Opt Express       Date:  2019-11-01       Impact factor: 3.732

3.  Adaptive optics two-photon excited fluorescence lifetime imaging ophthalmoscopy of photoreceptors and retinal pigment epithelium in the living non-human primate eye.

Authors:  Sarah Walters; James A Feeks; Khang T Huynh; Jennifer J Hunter
Journal:  Biomed Opt Express       Date:  2021-12-17       Impact factor: 3.562

4.  Fluorescence Lifetime Imaging Ophthalmoscopy: A Novel Way to Assess Macular Telangiectasia Type 2.

Authors:  Lydia Sauer; Rebekah H Gensure; Martin Hammer; Paul S Bernstein
Journal:  Ophthalmol Retina       Date:  2017-12-08

Review 5.  Fluorescence lifetime imaging ophthalmoscopy: autofluorescence imaging and beyond.

Authors:  Lydia Sauer; Alexandra S Vitale; Natalie K Modersitzki; Paul S Bernstein
Journal:  Eye (Lond)       Date:  2020-12-02       Impact factor: 3.775

6.  FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY (FLIO) PATTERNS IN CLINICALLY UNAFFECTED CHILDREN OF MACULAR TELANGIECTASIA TYPE 2 (MACTEL) PATIENTS.

Authors:  Lydia Sauer; Alexandra S Vitale; Karl M Andersen; Barbara Hart; Paul S Bernstein
Journal:  Retina       Date:  2020-04       Impact factor: 3.975

7.  Characterization of Retinitis Pigmentosa Using Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO).

Authors:  Karl M Andersen; Lydia Sauer; Rebekah H Gensure; Martin Hammer; Paul S Bernstein
Journal:  Transl Vis Sci Technol       Date:  2018-06-22       Impact factor: 3.283

8.  Patterns of Fundus Autofluorescence Lifetimes In Eyes of Individuals With Nonexudative Age-Related Macular Degeneration.

Authors:  Lydia Sauer; Rebekah H Gensure; Karl M Andersen; Lukas Kreilkamp; Gregory S Hageman; Martin Hammer; Paul S Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-03-20       Impact factor: 4.799

9.  Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) of Macular Pigment.

Authors:  Lydia Sauer; Karl M Andersen; Binxing Li; Rebekah H Gensure; Martin Hammer; Paul S Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-06-01       Impact factor: 4.799

10.  Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Eyes With Pigment Epithelial Detachments Due to Age-Related Macular Degeneration.

Authors:  Lydia Sauer; Christopher B Komanski; Alexandra S Vitale; Eric D Hansen; Paul S Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-07-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.